Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion type Assertion NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_head.
- NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_provenance.
- NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion evidence source_evidence_literature NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_provenance.
- NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion SIO_000772 15876981 NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_provenance.
- NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion wasDerivedFrom befree-20150227 NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_provenance.
- NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion wasGeneratedBy ECO_0000203 NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_provenance.